Raquel Germer Toja Couto

Raquel Germer Toja Couto

Auto-generated profile, based on publicly available information

Raquel Germer Toja Couto

Universidade Federal Fluminense

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2025 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
FNFrank Nunes
Frank Nunes
RCRaquel Germer Toja Couto
Raquel Germer Toja Couto
DADiane Xavier de Avila
Diane Xavier de Avila
ATAna Flavia Malheiros Torbey
Ana Flavia Malheiros Torbey
KLKárila Scarduelli Luciano
Kárila Scarduelli Luciano
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
Filamin C is an essential protein for the integrity of the sarcomere and cytoskeleton of cardiomyocytes. Pathogenic variants in the FLNC gene are associated with a wide range of cardiomyopathies and may present distinct phenotypes depending on the type of genetic alteration. Truncated variants are frequently associated with dilated and arrhythmogenic cardiomyopathy, while missense variants are more related to hypertrophic and restrictive forms. These phenotypic differences reflect the molecular and structural impact of the FLNC variant on filamin C [...] Abstract Filamin C is an essential protein for the integrity of the sarcomere and cytoskeleton of cardiomyocytes. Pathogenic variants in the FLNC gene are associated with a wide range of cardiomyopathies and may present distinct phenotypes depending on the type of genetic alteration. Truncated variants are frequently associated with dilated and arrhythmogenic cardiomyopathy, while missense variants are more related to hypertrophic and restrictive forms. These phenotypic differences reflect the molecular and structural impact of the FLNC variant on filamin C

29 August 2023 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
ATAna Flavia Malheiros Torbey
Ana Flavia Malheiros Torbey
ENErivelton Alessandro Do Nascimento
Erivelton Alessandro Do Nascimento
NNNágela Simão Vinhosa Nunes
Nágela Simão Vinhosa Nunes
ACAdriana Bastos Carvalho
Adriana Bastos Carvalho
DNDaniel Gama das Neves
Daniel Gama das Neves
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
Arrhythmogenic cardiomyopathy with exclusive or predominant involvement of the left ventricle has been described recently. It has a heterogeneous genetic basis with different clinical phenotypes ranging from ventricular arrhythmias and sudden death (SD), symptoms suggestive of acute myocarditis with chest pain and troponin elevation, symptoms of heart failure, to asymptomatic patients. A high level of suspicion is needed for a correct diagnosis and implementation of a genotype-based therapy, to prevent its most feared complication, SD. This review aims to [...] Abstract Arrhythmogenic cardiomyopathy with exclusive or predominant involvement of the left ventricle has been described recently. It has a heterogeneous genetic basis with different clinical phenotypes ranging from ventricular arrhythmias and sudden death (SD), symptoms suggestive of acute myocarditis with chest pain and troponin elevation, symptoms of heart failure, to asymptomatic patients. A high level of suspicion is needed for a correct diagnosis and implementation of a genotype-based therapy, to prevent its most feared complication, SD. This review aims to

9 February 2023
Verified
Book Chapter
Closed access
PDF file
RCRaquel Germer Toja Couto
Raquel Germer Toja Couto
ATAna Flávia Malheiros Torbey
Ana Flávia Malheiros Torbey
ASAurea Lucia Alves de Azevedo Grippa de Souza
Aurea Lucia Alves de Azevedo Grippa de Souza

20 October 2025 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
FNFrank Nunes
Frank Nunes
RCRaquel Germer Toja Couto
Raquel Germer Toja Couto
DADiane Xavier de Avila
Diane Xavier de Avila
ATAna Flavia Malheiros Torbey
Ana Flavia Malheiros Torbey
KLKárila Scarduelli Luciano
Kárila Scarduelli Luciano
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
A Filamina C é uma proteína essencial para a integridade do sarcômero e do citoesqueleto dos cardiomiócitos. Variantes patogênicas no gene FLNC estão associadas a uma ampla gama de cardiomiopatias, podendo apresentar fenótipos distintos de acordo com o tipo de alteração genética. As variantes truncadas estão frequentemente associadas à cardiomiopatia dilatada e arritmogênica, enquanto as variantes missense são mais relacionadas às formas hipertrófica e restritiva. Essas diferenças fenotípicas refletem o impacto molecular e estrutural da variante FLNC na proteína filamina C, com implicações diretas no manejo clínico. O diagnóstico e a estratificação de risco são desafiadores e exigem uma abordagem multimodal que integre dados clínicos, genéticos e de imagem. A ressonância magnética cardíaca, em especial, é fundamental para a detecção de fibrose miocárdica e para a avaliação prognóstica. Evidências recentes indicam que variantes patogênicas no FLNC também podem estar associadas, raramente, a casos de miocardite aguda de apresentação grave, frequentemente acompanhada de arritmias ventriculares malignas e disfunção sistólica. O diagnóstico preciso, o acompanhamento contínuo e o aconselhamento familiar são fundamentais para definir a melhor abordagem terapêutica e prognóstica dos pacientes, em especial daqueles com alto risco de morte súbita cardíaca (MSC), permitindo desta forma, intervenções personalizadas e preventivas.